패키지	데이터	기간	미국 소스 예시 ^*
회사 재무	10년	손익 계산서 현금 흐름표 대차 대조표	SEC 양식 10-K SEC 양식 10-Q
애널리스트 컨센서스 추정치	+3년	재무 예측 애널리스트 목표가	애널리스트 연구 보고서 Blue Matrix
시장 가격	30년	주식 가격 배당금, 분할 및 액션	ICE 시장 데이터 SEC 양식 S-1
소유권	10년	최대 주주 내부자 거래	SEC 양식 4 SEC 양식 13D
관리	10년	리더십 팀 이사회	SEC 양식 10-K SEC 양식 DEF 14A
주요 개발 사항	10년	회사 공지 사항	SEC 양식 8-K

* 미국 증권의 경우, 미국 외 지역의 규제 양식 및 출처는 미국 증권의 예를 사용했습니다.

명시되지 않는 한 모든 재무 데이터는 1년을 기준으로 하지만 분기별로 업데이트됩니다. 이를 후행 12개월(TTM) 또는 최근 12개월(LTM) 데이터라고 합니다. 자세히 알아보기.

분석 모델 및 눈송이

이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 Github 페이지에서 확인할 수 있으며, 보고서 사용 방법에 대한 가이드와 튜토리얼도 유튜브에서 확인할 수 있습니다.

Simply 월스트리트 분석 모델을 설계하고 구축한 세계적인 수준의 팀에 대해 알아보세요.

산업 및 부문 메트릭

업계 및 섹션 지표는 Simply Wall St에서 6시간마다 계산되며, 자세한 내용은 Github에서 확인할 수 있습니다.

애널리스트 출처

Vapotherm, Inc. 5 애널리스트 중 0 애널리스트가 보고서의 입력 자료로 사용된 매출 또는 수익 추정치를 제출했습니다. 애널리스트의 제출 자료는 하루 종일 업데이트됩니다.

분석가	교육기관
Robert Hopkins	BofA Global Research
Michael Gorman	BTIG
William Plovanic	Canaccord Genuity

This company has been acquired

Vapotherm 대차 대조표 상태

재무 상태 기준 확인 0/6

주요 정보

최근 재무 상태 업데이트

The New York Stock Exchange to Commence Delisting Proceedings against Vapotherm

Vapotherm Receives Price Cure Notification Letter from the NYSE Indicates its Stock Price Above the NYSE's Minimum Requirement

Vapotherm Announces NYSE Continued Listing Standard Notice

Is Vapotherm (NYSE:VAPO) Using Too Much Debt?

Health Check: How Prudently Does Vapotherm (NYSE:VAPO) Use Debt?

Does Vapotherm (NYSE:VAPO) Have A Healthy Balance Sheet?

Recent updates

Perceptive Discovery Fund LP, managed by Perceptive Advisors LLC completed the acquisition of Vapotherm, Inc. (OTCPK:VAPO) from a group of shareholders.

Perceptive Discovery Fund LP, managed by Perceptive Advisors LLC entered into definitive merger agreement to acquire Vapotherm, Inc. (OTCPK:VAPO) for $15.1 million.

Vapotherm, Inc. to Unveil Access365 Home Ventilation Solution at MEDTRADE

The New York Stock Exchange to Commence Delisting Proceedings against Vapotherm

Vapotherm, Inc. Revises Revenue Guidance for the Full Year 2023

Vapotherm, Inc. to Report Q3, 2023 Results on Nov 08, 2023

Vapotherm Announces Presentation of an Investigator-Initiated Clinical Trial, 'High Flow Humidified Oxygen as an Early Intervention in Children with Acute Severe Asthma - a Feasibility Randomized Controlled Trial' at the European Respiratory Society International Congress 2023

Vapotherm, Inc. Revises Earnings Guidance for Fiscal 2023

Vapotherm, Inc. to Report Q2, 2023 Results on Aug 08, 2023

Vapotherm, Inc. Reports Impairment of Long-Lived and Intangible Assets for the First Quarter Ended March 31, 2023

Vapotherm Receives Price Cure Notification Letter from the NYSE Indicates its Stock Price Above the NYSE's Minimum Requirement

Vapotherm, Inc. to Report Q4, 2022 Results on Feb 23, 2023

Vapotherm announces $23M private placement

Vapotherm, Inc. Provides Revenue Guidance for the Fourth Quarter of 2022

Vapotherm, Inc. Provides Revenue Guidance for 2022

Vapotherm GAAP EPS of -$0.98 misses by $0.20, revenue of $13.5M misses by $3.02M

Vapotherm, Inc. to Report Q3, 2022 Results on Nov 02, 2022

Vapotherm Announces NYSE Continued Listing Standard Notice

Vapotherm draws downgrade at William Blair after 2Q results

Vapotherm, Inc. Reports Unaudited Condensed Consolidated Impairment Charges for the Second Quarter Ended June 30, 2022

Vapotherm, Inc. to Report Q2, 2022 Results on Aug 03, 2022

Vapotherm, Inc. Plans to Move All of Its Manufacturing Operations from New Hampshire to Mexico

Price target decreased to US$4.83

Vapotherm, Inc.(NYSE:VAPO) dropped from Russell 2000 Growth Index

Vapotherm: Out Of Air

Vapotherm, Inc. Revises Earnings Guidance for the Fiscal Year 2022

Vapotherm, Inc., Annual General Meeting, Jun 21, 2022

Vapotherm, Inc. Provides Revenue Guidance for the First Quarter of 2022

Consensus forecasts updated

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Price target decreased to US$34.33

Vapotherm, Inc. Provides Consolidated Earnings Guidance for the Fiscal Year 2022

Vapotherm, Inc. to Report Q4, 2021 Results on Feb 24, 2022

Is Vapotherm (NYSE:VAPO) Using Too Much Debt?

Vapotherm, Inc. Announces Revenue Guidance for the Fourth Quarter of 2021, Full Year 2021 and 2022

Third quarter 2021 earnings released: US$0.52 loss per share (vs US$0.49 loss in 3Q 2020)

Chief Accounting Officer Joel Dube has left the company

Vapotherm, Inc. Revises Revenue Guidance for the Fiscal Year 2021

Vapotherm, Inc. Announces FDA 510(k) Clearance for HVT 2.0 Next Generation Platform

Senior VP notifies of intention to sell stock

Second quarter 2021 earnings released: US$0.67 loss per share (vs US$0.35 loss in 2Q 2020)

Senior VP & Chief Commercial Officer exercised options and sold US$170k worth of stock

Vapotherm: Hardly Breathing Room

Insider recently bought US$4.8m worth of stock

Independent Director Marina Hahn has left the company

Independent Chairman of the Board recently bought US$170k worth of stock

Health Check: How Prudently Does Vapotherm (NYSE:VAPO) Use Debt?

First quarter 2021 earnings released: US$0.40 loss per share (vs US$0.66 loss in 1Q 2020)

Vapotherm, Inc. Provides Financial Guidance for 2021

Vapotherm reports Q1 results

The Independent Director of Vapotherm, Inc. (NYSE:VAPO), Anthony Arnerich, Just Bought 59% More Shares

Independent Director recently bought US$109k worth of stock

Announcing: Vapotherm (NYSE:VAPO) Stock Increased An Energizing 225% In The Last Year

Full year 2020 earnings released: US$2.16 loss per share (vs US$2.74 loss in FY 2019)

Revenue and earnings beat expectations

New 90-day low: US$23.17

Vapotherm, Inc. to Report Q4, 2020 Results on Feb 24, 2021

Senior VP & Chief Commercial Officer notifies of intention to sell stock

Senior VP & Chief Commercial Officer exercised options and sold US$56k worth of stock

Does Vapotherm (NYSE:VAPO) Have A Healthy Balance Sheet?

Vapotherm guides Q4 revenue above consensus, ~212% Y/Y growth

New 90-day high: US$32.08

Thomas Smith of Vapotherm, Inc. (NYSE:VAPO) Just Spent US$217k On Shares

Insider recently bought US$217k worth of stock

Investors Who Bought Vapotherm (NYSE:VAPO) Shares A Year Ago Are Now Up 132%

Analysts update estimates

Vapotherm, Inc. Revises Revenue Guidance for the Fourth Quarter and Full Year 2020

Vapotherm shares +9% on higher Q4 guidance